Metabolic syndrome frequency in inflammatory bowel diseases
Background/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=Yorulmaz |
id |
doaj-3ecfe69853b04473889d960b6fdda159 |
---|---|
record_format |
Article |
spelling |
doaj-3ecfe69853b04473889d960b6fdda1592020-11-24T21:29:03ZengWolters Kluwer Medknow PublicationsThe Saudi Journal of Gastroenterology1319-37671998-40492011-01-0117637638210.4103/1319-3767.87177Metabolic syndrome frequency in inflammatory bowel diseasesElif YorulmazGupse AdaliHatice YorulmazCelal UlasogluGuralp TasanIlyas TuncerBackground/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD). This study sought to determine the prevalence of MetS in a Turkish cohort of patients with IBD and the association between insulin resistance (IR) and the MetS parameters, in this population. Patients and Methods: A total of 177 patients over 18 years of age (62 with Crohn′s disease (CD) and 115 with ulcerative colitis (UC)) were enrolled in the study. The presence of at least three criteria of the International Diabetes Federation (IDF) was accepted for the diagnosis of MetS. The Homeostasis Model Assessment (HOMA) was used to determine IR. HOMA values < 1 were considered normal and values > 2.5 indicated a high probability of IR. Results: MetS frequency was higher in patients n=34 (29.5%) with UC than in patients n=11 (17.7%) with CD (P < 0.01). MetS was detected in 12 of the 117 patients (10.3%) with IBD, under 45 years of age, and in 33 of 60 patients (55%) over 45 years of age. HOMA value in n=31 patients (27%) with UC was > 2.5. Body mass index, insulin (P < 0.001), waist circumference, fasting plasma glucose, leukocyte count (P < 0.01), triglycerides, C-reactive protein, and uric acid values (P < 0.05) were significantly higher in UC patients with IR than those without IR. Conclusion: Frequent occurrence of MS with increasing age in IBD, particularly in UC, showed the importance of early diagnosis and treatment of cardiovascular disease risk factors in the long-term follow-up of these diseases.http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=YorulmazInflammatory bowel diseaseinsulin resistancemetabolic syndromeobesity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Elif Yorulmaz Gupse Adali Hatice Yorulmaz Celal Ulasoglu Guralp Tasan Ilyas Tuncer |
spellingShingle |
Elif Yorulmaz Gupse Adali Hatice Yorulmaz Celal Ulasoglu Guralp Tasan Ilyas Tuncer Metabolic syndrome frequency in inflammatory bowel diseases The Saudi Journal of Gastroenterology Inflammatory bowel disease insulin resistance metabolic syndrome obesity |
author_facet |
Elif Yorulmaz Gupse Adali Hatice Yorulmaz Celal Ulasoglu Guralp Tasan Ilyas Tuncer |
author_sort |
Elif Yorulmaz |
title |
Metabolic syndrome frequency in inflammatory bowel diseases |
title_short |
Metabolic syndrome frequency in inflammatory bowel diseases |
title_full |
Metabolic syndrome frequency in inflammatory bowel diseases |
title_fullStr |
Metabolic syndrome frequency in inflammatory bowel diseases |
title_full_unstemmed |
Metabolic syndrome frequency in inflammatory bowel diseases |
title_sort |
metabolic syndrome frequency in inflammatory bowel diseases |
publisher |
Wolters Kluwer Medknow Publications |
series |
The Saudi Journal of Gastroenterology |
issn |
1319-3767 1998-4049 |
publishDate |
2011-01-01 |
description |
Background/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD). This study sought to determine the prevalence of MetS in a Turkish cohort of patients with IBD and the association between insulin resistance (IR) and the MetS parameters, in this population. Patients and Methods: A total of 177 patients over 18 years of age (62 with Crohn′s disease (CD) and 115 with ulcerative colitis (UC)) were enrolled in the study. The presence of at least three criteria of the International Diabetes Federation (IDF) was accepted for the diagnosis of MetS. The Homeostasis Model Assessment (HOMA) was used to determine IR. HOMA values < 1 were considered normal and values > 2.5 indicated a high probability of IR. Results: MetS frequency was higher in patients n=34 (29.5%) with UC than in patients n=11 (17.7%) with CD (P < 0.01). MetS was detected in 12 of the 117 patients (10.3%) with IBD, under 45 years of age, and in 33 of 60 patients (55%) over 45 years of age. HOMA value in n=31 patients (27%) with UC was > 2.5. Body mass index, insulin (P < 0.001), waist circumference, fasting plasma glucose, leukocyte count (P < 0.01), triglycerides, C-reactive protein, and uric acid values (P < 0.05) were significantly higher in UC patients with IR than those without IR. Conclusion: Frequent occurrence of MS with increasing age in IBD, particularly in UC, showed the importance of early diagnosis and treatment of cardiovascular disease risk factors in the long-term follow-up of these diseases. |
topic |
Inflammatory bowel disease insulin resistance metabolic syndrome obesity |
url |
http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=Yorulmaz |
work_keys_str_mv |
AT elifyorulmaz metabolicsyndromefrequencyininflammatoryboweldiseases AT gupseadali metabolicsyndromefrequencyininflammatoryboweldiseases AT haticeyorulmaz metabolicsyndromefrequencyininflammatoryboweldiseases AT celalulasoglu metabolicsyndromefrequencyininflammatoryboweldiseases AT guralptasan metabolicsyndromefrequencyininflammatoryboweldiseases AT ilyastuncer metabolicsyndromefrequencyininflammatoryboweldiseases |
_version_ |
1725967812285956096 |